Lidocaine recalls

Lidocaine products have been recalled 8 times, most recently on 29 Jul 2026. The recalling company is usually Novocol Pharmaceutical of Canada. The most common reason is packaging defects.

Total recalls8since 2013

Last 12 months2reported

Class I00% of total

Ongoing3latest 29 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 1 0Jan '26 0 0 0Apr 0 0 1Jul 0 0

Severity split

Class I 0 0%Class II 6 75%Class III 2 25%

Why lidocaine is recalled

Companies

Product types

Pain Medication8100%

By year

2026113%
2025113%
2023113%
2022225%
2020113%
2018113%
2013113%

Ongoing lidocaine recalls

3 active

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Lidocaine HCl Injection, USP, 2%, 100 mg recalled by Fresenius Kabi USALidocaine	Fresenius Kabi USA	Particulate Matter	Nationwide
24 Dec 2025Drug	CLASS II	Lidocaine HCI 2% and Epinephrine 1:100 recalledLidocaine	Novocol Pharmaceutical of Canada	Packaging Defects	Nationwide
10 May 2023Drug	CLASS III	Lidocaine Patch 5%, 1 patch (63629-8755-20) recalledLidocaine	Bryant Ranch Prepack	Packaging Defects	Nationwide

All lidocaine recalls, newest first

8 total

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Lidocaine HCl Injection, USP, 2%, 100 mg recalled by Fresenius Kabi USALidocaine	Fresenius Kabi USA	Particulate Matter	Nationwide
24 Dec 2025Drug	CLASS II	Lidocaine HCI 2% and Epinephrine 1:100 recalledLidocaine	Novocol Pharmaceutical of Canada	Packaging Defects	Nationwide
10 May 2023Drug	CLASS III	Lidocaine Patch 5%, 1 patch (63629-8755-20) recalledLidocaine	Bryant Ranch Prepack	Packaging Defects	Nationwide
15 Jun 2022Drug	CLASS II	Lidocaine Patch recalled by Mckesson Medical-SurgicalLidocaine	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
15 Jun 2022Drug	CLASS II	Lidocaine Patch recalled by Mckesson Medical-SurgicalLidocaine	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
19 Aug 2020Drug	CLASS II	Lidocaine Patch recalled by Teva Pharmaceuticals ULidocaine	Teva Pharmaceuticals U	Packaging Defects	Nationwide
30 May 2018Drug	CLASS III	Lidocaine Patch 5% (700 mg) recalled by Teva Pharmaceuticals ULidocaine	Teva Pharmaceuticals U	Potency & Assay	PA
4 Sep 2013Drug	CLASS II	Lidocaine Hydrochloride 2% and Epinephrine 1:100,000 Injection recalledLidocaine	Novocol Pharmaceutical of Canada	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.